Article
The nitric oxide-donor molsidomine modulates the innate inflammatory response in a mouse model of muscular dystrophy.
European journal of pharmacology - 5 Sept 2013
Zordan Paola, Sciorati Clara, Campana Lara, Cottone Lucia, Clementi Emilio, Querini Patrizia-Rovere, Brunelli Silvia
Abstract excerpt
Inflammation plays a crucial role in muscle remodeling and repair after acute and chronic damage, in particular in muscular dystrophies, a heterogeneous group of genetic diseases leading to muscular degeneration. Defect of nitric oxide (NO) generation is a key pathogenic event in muscular dystrophies, thus NO donors have been explored as new therapeutics for this disease. We have investigated the...
Topics
Join the communities discussing this publication.
